Boutique Healthcare Advisory

Based in the UK and Switzerland. Our primary expertise lies in oncology (including ATMPs and diagnostics) and immunology
Focus on innovative approaches to market access in European Markets, with strong links to experience and expertise in other disease areas and geographies.

It was great to meet you at the Poster Zone of the World Evidence Pricing Access (EPA) congress in Amsterdam

Dedicated Expertise

Bringing over 40 years of industry
and consulting experience

We provide access to more than 40 years of experience and expertise in pharmaceutical market access and management science across industry, consultancy, and healthcare systems.

We offer advisory, access, and analytic services across a broad range of approaches to healthcare, including:

· Advanced Therapies (ATMPs) – medicines that are based on genes, tissues, or cells.
· Genomic medicine - biomarker informed personalised healthcare.
· Digital health - including monitoring, intervention, and prediction.
· Traditional Therapies – new small molecule and biologic innovation, generics and biosimilar
‍

Our analytic services include support to:
‍
- Cell and Gene Therapy Commercial Analysis
- Early Asset Assessment and In/Out Licensing Evaluation
- Light-touch Pricing Assessment
- Portfolio Optimisation
- Resource allocation based on dynamic difference and adaptive methodologies.
- Forecasting support based on system dynamics and monte-carlo simulation.

We provide advice and training to all levels on Healthcare Systems, Market Access, and on a wide range of methodologies:
‍

“We’ve relied on them on several occasions where client discretion was of the utmost importance”

Joe Thompson — IP Client

“We wouldn't feel comfortable trusting anyone else to represent our company in legal matters”

Helen McNaught — Patent Law Client

the next step?

Request a consultation call

Get in touch for an obligation free consultation.